Capitalization 55.68B 7.65B P/E ratio 2024 *
18.5x
P/E ratio 2025 * 15.1x
Enterprise value 80.96B 11.13B EV / Sales 2024 *
1.62x
EV / Sales 2025 * 1.51x
Free-Float
63.46%
Yield 2024 *
1.7%
Yield 2025 * 2.04%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.86%
1 week+4.85%
Current month+6.50%
1 month+5.03%
3 months+3.69%
6 months+6.03%
Current year-5.79%
More quotes
1 week
22.62
Extreme 22.62
23.65
1 month
21.62
Extreme 21.62
23.65
Current year
20.38
Extreme 20.38
25.89
1 year
20.38
Extreme 20.38
32.08
3 years
20.38
Extreme 20.38
91.69
5 years
20.38
Extreme 20.38
91.69
10 years
16.50
Extreme 16.5
91.69
More quotes
Manager TitleAgeSince
Director of Finance/CFO 44 16-12-31
President 55 20-10-28
Chief Tech/Sci/R&D Officer 60 -
Director TitleAgeSince
Director/Board Member 52 94-03-31
Director/Board Member 74 07-05-27
Chairman 54 04-03-31
More insiders

Other Pharmaceuticals

Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.86%+4.85%-23.19%-69.69% 7.84B
+2.22%-6.26%+92.16%+261.52% 780B
+1.41%-5.28%+67.05%+221.88% 588B
-1.59%+0.79%-11.03%-11.40% 371B
-0.56%-0.73%+14.47%+60.60% 318B
+0.41%+2.94%+21.65%+47.37% 307B
-2.41%+5.87%+0.22%-21.08% 254B
-0.59%+0.98%+13.34%+44.08% 245B
-0.23%-2.90%+5.76%+13.55% 219B
-0.58%+0.48%+42.18%+35.12% 180B
Average -0.08%-0.06%+22.26%+58.20% 327.04B
Weighted average by Cap. +0.33%-2.33%+39.89%+115.63%
See all sector performances
Ratios2024 *2025 *
Net sales 43.96B 6.04B 48.54B 6.67B
Net income 3.5B 481M 3.96B 544M
Net Debt 15.46B 2.13B 17.72B 2.44B
More financial data * Estimated data
Logo Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical group organized around 4 areas of activities: - research, development and manufacturing of medicines (72.1% of net sales): for the treatment of cardiovascular diseases, digestive tract, metabolism, central nervous system and blood system disorders, and infectious diseases; - sale of medical equipments and diagnosis products (17.3%); - medical and hospital services (10.5%); - other (0.1%). China accounts for 72.9% of net sales.
Employees
40,370
Calendar
More about the company
Date Price Change Volume
24-07-23 23.02 ¥ -2.37% 10,372,070
24-07-22 23.58 ¥ +0.86% 10,622,610
24-07-19 23.38 ¥ +1.04% 10,813,580
24-07-18 23.14 ¥ +0.43% 9,596,692
24-07-17 23.04 ¥ +1.63% 11,064,720

End-of-day quote Shanghai S.E., July 21, 2024

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
23.58CNY
Average target price
28.61CNY
Spread / Average Target
+21.32%
Consensus
  1. Stock Market
  2. Equities
  3. 600196 Stock